HemoSonics Company & Industry News

June 19, 2021

Newsletter

FDA Supports Viscoelastic Coagulation Analyzers for COVID-19 Patients

Tag(s): company news, news

Read

Upcoming Events:

Δ

Comments

This field is for validation purposes and should be left unchanged.

Name(Required)

Email(Required)

Phone(Required)

Org/Company(Required)

Location(Required)

Comments

CAPTCHA

Contact Us

HemoSonics, LLC

4020 Stirrup Creek Dr, Suite 105 Durham, NC 27703-8970
USA

HemoSonics International

HemoSonics Europe

3 Allée Theresa, 92600
Asnières-sur-Seine
France

Phone: US: +1 (800) 280 5589
Contact: [email protected]
Support Contact: +1 (800) 280 5589
Support Email: [email protected]

Phone: +33 1 46 88 20 80
Email: [email protected]

The Quantra^® System with QPlus^® Cartridge is available for commercial use in the USA (registration number: DEN 180017) and Europe (IVDR certificate number: 39964) at the point-of-care and/or in medical laboratories. It is indicated for use with patients 18 years of age or older where an evaluation of their blood coagulation properties is desired. Coagulation evaluations are commonly used to assess clinical conditions in surgery (e.g., cardiovascular and orthopedic surgeries) to assess risk of hemorrhage and thrombosis before, during, and following the procedure.

The QStat^® Cartridge is available for commercial use in the USA (510k registration number: K251404) and Europe (IVDR certificate number: 39965) at the point-of-care and/or in medical laboratories. It is indicated for the evaluation of blood coagulation and clot lysis in patients age 18 years and older to assess possible hypocoagulable and hypercoagulable conditions in trauma, liver transplantation, and peripartum obstetric procedures.

Cookie Policy
Disclaimer
Privacy Policy